MDT
美敦力 Medtronic plc
+0.17 (+0.18%)92.77USD1.9M成交股數119B市值22.9本益比(近四季)3.2股價營收比+13.7%營收年增(近四季)2026-11-17下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 4 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 9.8B+14% | 9.8B+10% | 9.0B+9% | 9.0B+7% | 8.6B+8% | 8.9B+4% | 8.3B+3% | 8.4B+5% | 7.9B | 8.6B | 8.1B | 8.0B |
| 營業成本 | 3.4B | 3.4B | 3.3B | 3.1B | 3.0B | 3.1B | 2.8B | 2.9B | 2.8B | 3.0B | 2.8B | 2.8B |
| 毛利 | 6.3B+14% | 6.4B+11% | 5.8B+4% | 5.9B+8% | 5.6B+8% | 5.8B+4% | 5.5B+4% | 5.5B+4% | 5.2B | 5.5B | 5.3B | 5.2B |
| 毛利率 | 65.0% | 65.4% | 63.8% | 65.8% | 65.0% | 64.8% | 66.5% | 64.9% | 65.1% | 64.5% | 65.6% | 65.4% |
| 研發費用 | 771M | 671M | 722M | 754M | 726M | 684M | 675M | 697M | 676M | 674M | 695M | 698M |
| 銷售管理費用 | 3.2B | 3.1B | 3.0B | 3.0B | 2.8B | 2.7B | 2.7B | 2.8B | 2.7B | 2.8B | 2.7B | 2.7B |
| 營業利益 | 1.8B+22% | 1.9B+30% | 1.5B-11% | 1.7B+6% | 1.4B+13% | 1.4B+36% | 1.6B+11% | 1.6B+19% | 1.3B | 1.1B | 1.5B | 1.3B |
| 營業利益率 | 18.1% | 19.1% | 16.2% | 18.8% | 16.8% | 16.1% | 19.9% | 19.0% | 16.1% | 12.3% | 18.3% | 16.8% |
| 稅後淨利 | 1.5B+41% | −3.6B-1% | 1.1B-12% | 1.4B+8% | 1.0B-0% | −3.6B+19% | 1.3B-2% | 1.3B+40% | 1.0B | −3.0B | 1.3B | 909M |
| 淨利率 | 15.1% | -36.3% | 12.7% | 15.3% | 12.1% | -40.4% | 15.6% | 15.1% | 13.2% | -35.2% | 16.3% | 11.4% |
| 稀釋 EPS | 1.14+41% | 0.96+19% | 0.89-12% | 1.07+8% | 0.81+1% | 0.81+62% | 1.01+2% | 0.99+46% | 0.80 | 0.50 | 0.99 | 0.68 |
| 稀釋股數 | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.29B | 1.30B | 1.33B | 1.33B | 1.33B |
資產負債表 期末餘額
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.7B | 1.9B | 1.1B | 1.3B | 1.3B | 2.2B | 1.2B | 1.4B | 1.3B | 1.3B | 1.6B | 1.3B |
| 應收帳款 | 6.4B | 6.6B | 6.4B | 6.4B | 6.3B | 6.5B | 6.1B | 6.3B | 6.0B | 6.1B | 6.0B | 5.9B |
| 存貨 | 6.2B | 6.0B | 6.3B | 6.2B | 5.9B | 5.5B | 5.6B | 5.5B | 5.4B | 5.2B | 5.7B | 5.8B |
| 總資產 | 93.3B | 93.0B | 91.5B | 91.3B | 91.0B | 91.7B | 90.0B | 90.0B | 89.7B | 90.0B | 90.8B | 90.1B |
| 有息負債 | 25.6B | 26.2B | 27.9B | 27.7B | 26.2B | 25.6B | 24.0B | 24.6B | 26.3B | 23.9B | 24.2B | 23.7B |
| 總負債 | 42.5B | 43.0B | 42.3B | 42.5B | 42.8B | 43.4B | 40.4B | 41.3B | 41.6B | 39.6B | 38.8B | 38.4B |
| 股東權益 | 50.2B | 49.5B | 49.0B | 48.7B | 47.9B | 48.0B | 49.4B | 48.5B | 47.9B | 50.2B | 51.8B | 51.5B |
| 負債比 | 45.5% | 46.2% | 46.2% | 46.5% | 47.1% | 47.4% | 44.9% | 45.9% | 46.3% | 44.0% | 42.8% | 42.7% |
| 淨現金(現金 − 有息負債) | −23.9B | −24.2B | −26.7B | −26.4B | −24.9B | −23.4B | −22.7B | −23.2B | −25.0B | −22.6B | −22.5B | −22.4B |
現金流量表 單季
| 科目 | 27Q1 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | 1.8B+65% | – | – | – | 1.1B+10% | – | – | – | 986M | – | – | – |
| 資本支出 | 503M | – | – | – | 504M | – | – | – | 520M | – | – | – |
| 自由現金流 | 1.3B+121% | – | – | – | 584M+25% | – | – | – | 466M | – | – | – |
| 折舊攤銷 | 729M | – | – | – | 748M | – | – | – | 662M | – | – | – |
| 買回庫藏股 | 267M | – | – | – | 123M | – | – | – | 2.5B | – | – | – |
| 現金股利 | 921M | – | – | – | 910M | – | – | – | 898M | – | – | – |
| 自由現金流率 | 13.2% | – | – | – | 6.8% | – | – | – | 5.9% | – | – | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 36.3B
| Cardiovascular | 14.0B | 38.5% | +12.0% |
|---|---|---|---|
| Neuroscience Group | 10.3B | 28.3% | +4.5% |
| Medical Surgical | 8.8B | 24.3% | +4.9% |
| Diabetes Group | 3.1B | 8.6% | +13.0% |
| Other Operating Segment Misc | 135M | 0.4% | -1.5% |
| Total Reportable Segments 小計 | 33.1B | 91.1% | +7.6% |
| Other Operating Segments Including Diabetes 小計 | 3.2B | 8.9% | +12.3% |
地區2026 年度 · 18.2B
| 美國 | 18.1B | 99.2% | +5.4% |
|---|---|---|---|
| 愛爾蘭 | 143M | 0.8% | +23.3% |
| Total Other Countries Excluding Ireland 小計 | 36.2B | 198.5% | +8.4% |
| 美國以外 小計 | 18.3B | 100.1% | +11.6% |
| Total Other Countries Excluding United Statesand Ireland 小計 | 18.1B | 99.3% | +11.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 36.4B | +8.4% | 5K | 0.0% | 3.73 | 5.4B |
| FY2025 | 33.5B | +3.6% | 5K | 0.0% | 3.61 | 5.2B |
| FY2024 | 32.4B | +3.6% | 4K | 0.0% | 2.76 | 5.2B |
| FY2023 | 31.2B | -1.4% | 4K | 0.0% | 2.82 | 4.6B |
| FY2022 | 31.7B | +5.2% | 5K | 0.0% | 3.73 | 6.0B |
| FY2021 | 30.1B | +4.2% | 3.6B | 12.0% | 2.66 | 4.9B |
| FY2020 | 28.9B | -5.4% | 4.8B | 16.6% | 3.54 | 6.0B |
| FY2019 | 30.6B | – | 4.6B | 15.2% | 3.41 | 5.9B |